The first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)
BrandinstituteAugust 1, 2020
All | Rx Brand | Nonproprietary (USAN/INN) | Covid-19 | Consumer | Brand Showcase | Medical Device | Sponsorship | DSI Guidance | BI Culture
Digital Health and Digital Therapeutics are becoming increasingly relevant and in-demand
considering the COVID-19...
BrandinstituteApril 8, 2020
We are proud to have partnered with you and hope to work on your next naming project!...
BrandinstituteMarch 1, 2020
For the second time in a row, a BioMarin drug brand name has won FierceBiotech’s …
BrandinstituteApril 20, 2018